Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Cvs Health Corp. for the product Omeprazole Magnesium (NDC 69842-027). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each capsule), purpose, use, warnings, do not use if you have, ask a doctor before use if you have, ask a doctor or pharmacist before use if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
*Omeprazole delayed-release capsules 20 mg
(equivalent to 20.6 mg omeprazole magnesium)
Acid reducer
Allergy alert: Do not use if you are allergic to omeprazole
you are taking:
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
14- day Course of Treatment
Repeated 14-Day Courses (if needed)
black iron oxide, dibasic calcium phosphate, gelatin, glyceryl monostearate, hypromellose 3 cps, magnesium oxide, magnesium stearate, methacrylic acid copolymer dispersion, methacrylic acid copolymer Type B, microcrystalline cellulose, polysorbate 80, potassium hydroxide, propylene glycol, red iron oxide, shellac, silicon dioxide, sodium lauryl sulphate, sugar spheres, talc, titanium dioxide, triethyl citrate
Call 1-888-375-3784
* Please review the disclaimer below.